Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014–2017.
Open accessAbstract
We evaluated clinical outcomes among organ recipients with donor-derived hepatitis B virus (HBV) or hepatitis C virus (HCV) infections investigated by CDC from 2014 to 2017 in the United States. We characterized new HBV infections in organ recipients if donors tested negative for total anti-HBc, HBsAg and HBV DNA, and new recipient HCV infections if donors tested negative for anti-HCV and HCV RNA. Donor risk behaviors were abstracted from next-of-kin interviews and medical records. During 2014-2017, seven new recipient HBV infections associated with seven donors were identified; six (86%) recipients survived. At last follow-up, all survivors had functioning grafts and five (83%) had started antiviral therapy. Twenty new recipient HCV infections associated with nine donors were identified; 19 (95%) recipients survived. At last follow-up, 18 (95%) survivors had functioning grafts and 14 (74%) had started antiviral treatment. Combining donor next-of kin interviews and medical records, 11/16 (69%) donors had evidence of injection drug use and all met Public Health Service increased risk donor (IRD) criteria. IRD designation led to early diagnosis of recipient infection, and prompt implementation of therapy, likely reducing the risk of graft failure, liver disease, and death.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Transmission of HCV after receipt of blood from donors and from transplantation of tissues and organs with HCV infection has occurred only rarely since 1992, when routine screening of these donated products was mandated in the United States.
“Transmission after receipt of blood from donors and from transplantation of tissues and organs with HCV infection has occurred only rarely since 1992, when routine screening of these donated products was mandated in the United States (1367,1369).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [1369]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K., Hwang, J. P., Jonas, M. M., Brown, R. S., Bzowej, N. H., & Wong, J. B. (2018) · Hepatology · doi:10.1002/hep.29800 · Cited by 4,306 · see citing works
Liver Transplantation in European Patients with the Hepatitis B Surface Antigen
Samuel, D., Müller, R., Alexander, G., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312163292503 · Cited by 1,047 · see citing works
Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends
Wasley, A., & Alter, M. J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9506 · Cited by 986 · see citing works
Reddy, K. R., Beavers, K. L., Hammond, S. P., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.10.039 · Cited by 861 · see citing works
Understanding diagnostic tests 1: sensitivity, specificity and predictive values
Akobeng, A. K. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2006.00180.x · Cited by 711 · see citing works
Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B. A., Iqbal, K., Ward, J. W., & Holtzman, D. J. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.304132 · Cited by 699 · see citing works
HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015
Peters, P. J., Pontones, P. R., Hoover, K. W., Patel, M. R., Galang, R. R., Shields, J., Blosser, S. J., Spiller, M. W., Combs, B., Switzer, W. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515195 · Cited by 594 · see citing works
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease
Todo, S., Demetris, A. J., Thiel, D. V., et al. (1991) · Hepatology · doi:10.1002/hep.1840130402 · Cited by 563 · see citing works
Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients
Goldberg, D. S., Abt, P. L., Blumberg, E. A., Deerlin, V. M. V., Levine, M. H., Reddy, K. R., Bloom, R. D., Nazarian, S. M., Sawinski, D. L., Porrett, P. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1705221 · Cited by 363 · see citing works
Seem, D. L., Lee, I., Umscheid, C. A., & Kuehnert, M. J. (2013) · Public Health Reports · doi:10.1177/003335491312800403 · Cited by 234 · see citing works
Twelve-Month Outcomes After Transplant of Hepatitis C–Infected Kidneys Into Uninfected Recipients
Reese, P. P., Abt, P. L., Blumberg, E. A., Deerlin, V. M. V., Bloom, R. D., Potluri, V. S., Levine, M. H., Porrett, P. M., Sawinski, D. L., Nazarian, S. M., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0749 · Cited by 225 · see citing works
Virology and cell biology of the hepatitis C virus life cycle – An update
Dubuisson, J., & Cosset, F. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.031 · Cited by 222 · see citing works
The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States
Durand, C. M., Bowring, M. G., Thomas, A. G., Kucirka, L. M., Massie, A. B., Cameron, A. M., Desai, N. M., Sulkowski, M., & Segev, D. L. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2451 · Cited by 201 · see citing works
Bersoff‐Matcha, S. J., Cao, K., Jason, M., Ajao, A. O., Jones, S. C., Meyer, T. E., & Brinker, A. D. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0377 · Cited by 187 · see citing works
Colombo, M. G., Aghemo, A., Liu, H., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-1205 · Cited by 182 · see citing works
Cranston, K., Alpren, C., John, B., Dawson, E., Roosevelt, K. A., Burrage, A. B., Bryant, J., Switzer, W. M., Breen, C., Peters, P. J., et al. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6810a6 · Cited by 178 · see citing works
Self-citationLaboratory Diagnostics for Hepatitis C Virus Infection
Kamili, S., Drobeniuc, J., de Araujo, A. C., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis368 · Cited by 173 · see citing works
Self-citationKucirka, L. M., Sarathy, H., Govindan, P., Wolf, J. H., Ellison, T. A., Hart, L. J., Montgomery, R. A., Ros, R. L., & Segev, D. L. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03329.x · Cited by 170 · see citing works
The Molecular Virology of Hepatitis B Virus
Bremer, C. M., & Glebe, D. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1345717 · Cited by 167 · see citing works
Humar, A., Morris, M. I., Blumberg, E. A., Freeman, R. B., Preiksaitis, J. K., Kiberd, B. A., Schweitzer, E. J., Ganz, S. S., Caliendo, A. M., ORLOWSKI, J. P., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02992.x · Cited by 165 · see citing works
Hepatitis C Virus Seropositivity in Organ Donors and Survival in Heart Transplant Recipients
Gasink, L. B., Blumberg, E. A., Localio, A. R., Desai, S., Israni, A. K., & Lautenbach, E. (2006) · JAMA · doi:10.1001/jama.296.15.1843 · Cited by 159 · see citing works
Kucirka, L. M., Sarathy, H., Govindan, P., Wolf, J. H., Ellison, T. A., Hart, L. J., Montgomery, R. A., Ros, R. L., & Segev, D. L. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03460.x · Cited by 150 · see citing works
Tugwell, B. D., Patel, P. R., Williams, I. T., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-9-200511010-00008 · Cited by 141 · see citing works
Ison, M. G., Llata, E., Conover, C. S., et al. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03597.x · Cited by 134 · see citing works
Increases in Acute Hepatitis B Virus Infections — Kentucky, Tennessee, and West Virginia, 2006–2013
Harris, A. M., Iqbal, K., Schillie, S. F., Britton, J., Kainer, M. A., Tressler, S. R., & Vellozzi, C. J. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6503a2 · Cited by 129 · see citing works
Protective Immunity Against Hepatitis C: Many Shades of Gray
Abdel-Hakeem, M. S., & Shoukry, N. H. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00274 · Cited by 94 · see citing works
Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection—the InC 3 Study
Sacks‐Davis, R., Grebely, J., Dore, G. J., Osburn, W. O., Cox, A. L., Rice, T., Spelman, T., Bruneau, J., Prins, M., Kim, A. Y., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv220 · Cited by 94 · see citing works
The natural history of hepatitis C cirrhosis after liver transplantation
Firpi, R. J., Clark, V., Soldevila‐Pico, C., et al. (2009) · Liver Transplantation · doi:10.1002/lt.21784 · Cited by 92 · see citing works
Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys
Bowring, M. G., Holscher, C. M., Zhou, S., Massie, A. B., Garonzik‐Wang, J., Kucirka, L. M., Gentry, S. E., & Segev, D. L. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14577 · Cited by 92 · see citing works
The “PHS Increased Risk” Label Is Associated With Nonutilization of Hundreds of Organs per Year
Volk, M. L., Wilk, A. R., Wolfe, C. R., et al. (2017) · Transplantation · doi:10.1097/tp.0000000000001673 · Cited by 85 · see citing works
Perioperative Ledipasvir–Sofosbuvir for HCV in Liver-Transplant Recipients
Levitsky, J., Verna, E. C., O’Leary, J. G., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1611829 · Cited by 80 · see citing works
The rise of the opioid epidemic and hepatitis C–positive organs: A new era in liver transplantation
Gonzalez, S. A., & Trotter, J. F. (2017) · Hepatology · doi:10.1002/hep.29572 · Cited by 78 · see citing works
Transmission of Hepatitis C Virus From Organ Donors Despite Nucleic Acid Test Screening
Suryaprasad, S., Basavaraju, S. V., Hocevar, S. N., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13283 · Cited by 72 · see citing works
Self-citationHIV Transmitted from a Living Organ Donor—New York City, 2009
(2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03631.x · Cited by 63 · see citing works
Deceased Organ Donors and PHS Risk Identification
Pruett, T. L., Clark, M. A., & Taranto, S. E. (2017) · Transplantation · doi:10.1097/tp.0000000000001716 · Cited by 59 · see citing works
Mixson-Hayden, T. R., Lee, D., Ganova-Raeva, L. M., et al. (2014) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0068 · Cited by 58 · see citing works
Self-citationAbara, W. E., Collier, M. G., Moorman, A. C., Bixler, D., Jones, J. M., Annambhotla, P. D., Bowman, J., Levi, M. E., Brooks, J. T., & Basavaraju, S. V. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6803a2 · Cited by 58 · see citing works
Self-citationImpact of donor and recipient hepatitis C status in lung transplantation
Englum, B. R., Ganapathi, A. M., Speicher, P. J., Gulack, B. C., Snyder, L. D., Davis, R. D., & Hartwig, M. G. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.10.012 · Cited by 56 · see citing works
Croome, K. P., Lee, D. D., Pungpapong, S., et al. (2018) · Liver Transplantation · doi:10.1002/lt.25009 · Cited by 40 · see citing works
(2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04024.x · Cited by 32 · see citing works
Impact of Hepatitis C Infection on Outcomes After Heart Transplantation
Fong, T., Hou, L. A., Hutchinson, I. V., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181bd3e59 · Cited by 31 · see citing works
Peveling‐Oberhag, J., Zeuzem, S., & Hofmann, W. P. (2009) · Medical Microbiology and Immunology · doi:10.1007/s00430-009-0131-8 · Cited by 28 · see citing works
Moayedi, Y., Gulamhusein, A. F., Ross, H. J., et al. (2018) · Clinical Transplantation · doi:10.1111/ctr.13308 · Cited by 26 · see citing works
Fleetwood, V. A., Lusciks, J., Poirier, J., et al. (2016) · Journal of Transplantation · doi:10.1155/2016/9658904 · Cited by 20 · see citing works
(2003) · PubMed · Cited by 15 · see citing works
Maluf, D. G., Archer, K. J., Villamil, F. G., et al. (2010) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.39 · Cited by 13 · see citing works
Transmissibility of intra-host hepatitis C virus variants
Campo, D. S., Zhang, J., Ramachandran, S., & Khudyakov, Y. E. (2017) · BMC Genomics · doi:10.1186/s12864-017-4267-4 · Cited by 11 · see citing works
Self-citationIntroduction to hepatitis B transplantation.
Jm, V., & Teperman, L. W. (2000) · PubMed · Cited by 10 · see citing works
Management of Viral Hepatitis in Solid Organ Transplant Recipients
Buganza‐Torio, E., & Doucette, K. E. (2018) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2018.04.010 · Cited by 9 · see citing works
Notes From the Field: Transplant-Transmitted Hepatitis B Virus—United States, 2010
(2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03988.x · Cited by 6 · see citing works
Notes from the field: transplant-transmitted hepatitis B virus --- United States, 2010.
(2011) · PubMed · Cited by 3 · see citing works
Choe, J. K., Merola, J., Kulkarni, S., et al. (2017) · Clinical Transplantation · doi:10.1111/ctr.13022 · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- [18]Abarra W, Collier MG, Moorman A, Trends in Deceased Solid Organ Donor Characteristics and Hepatitis B, C, and HIV Screening Results in the Opioid Epidemic Era—United States, 2010–2017. MMWR. 2019; 68(3): 61– 66. 30677008 PMC6348762
- [33]Ison MG, Llata E, Conovere CS, Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients. Am J Transplant. 2011; 11: 1218– 1225. 21645254
Cited by
Sorted by citations
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 2,759 · see citing works
- Authors
- Bixler, D., Annambholta, P., Abara, W. E., Collier, M. G., Jones, J., Mixson-Hayden, T., Basavaraju, S. V., Ramachandran, S., Kamili, S., & Moorman, A.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Bixler, Danae
- ORCID
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 19
- Issue
- 9
- Pages
- 2570-2582
- ISSN
- 1600-6135 (ISSN-L)
- PMC
- PMC9112229
- OpenAlex
- W2921694930
- Cited by
- 29
- References
- 54
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 6 · 2021: 7 · 2020: 4 · 2019: 4
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- American Journal of Transplantation (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CC999999)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- hepatitis B virus, hepatitis C virus, donor-derived infection, organ transplantation, liver transplantation, graft failure, antiviral therapy, intravenous drug use, clinical outcomes
- MeSH terms
- Adult, Antiviral Agents, Centers for Disease Control and Prevention, U.S., Female, Graft Survival, Hepatitis B, Hepatitis B Antibodies, Hepatitis B Core Antigens, Hepatitis B Surface Antigens, Hepatitis B virus, Hepatitis C, Humans, Male, Middle Aged, Tissue and Organ Procurement, Risk-Taking, RNA, Viral, Tissue Donors, United States, Substance Abuse, Intravenous, Hepacivirus, Organ Transplantation, Treatment Outcome, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
